Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.
|
Exp Neurol
|
2002
|
1.89
|
2
|
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
|
FASEB J
|
2002
|
1.79
|
3
|
Neuroendocrine aspects of the response to stress.
|
Metabolism
|
2002
|
1.71
|
4
|
Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
|
FASEB J
|
2006
|
1.61
|
5
|
Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
|
J Biol Chem
|
2004
|
1.57
|
6
|
Divergent roles for tumor necrosis factor-alpha in the brain.
|
J Neuroimmune Pharmacol
|
2007
|
1.54
|
7
|
Work, obesity, and occupational safety and health.
|
Am J Public Health
|
2007
|
1.53
|
8
|
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
|
J Neurochem
|
2006
|
1.49
|
9
|
Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
|
J Neurosci
|
2008
|
1.48
|
10
|
Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
|
Pain Med
|
2010
|
1.47
|
11
|
Astrogliosis in CNS pathologies: is there a role for microglia?
|
Mol Neurobiol
|
2010
|
1.38
|
12
|
Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2.
|
Am J Pathol
|
2007
|
1.31
|
13
|
Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I.
|
J Clin Invest
|
2007
|
1.07
|
14
|
Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.
|
Proc Natl Acad Sci U S A
|
2008
|
1.04
|
15
|
Sample-dependent effects on the neuropeptidome detected in rat brain tissue preparations by capillary liquid chromatography with tandem mass spectrometry.
|
Anal Chem
|
2005
|
1.03
|
16
|
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
|
J Pain
|
2009
|
1.02
|
17
|
Identification and quantification of neuropeptides in brain tissue by capillary liquid chromatography coupled off-line to MALDI-TOF and MALDI-TOF/TOF-MS.
|
Anal Chem
|
2006
|
1.00
|
18
|
Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine.
|
J Neurochem
|
2012
|
0.98
|
19
|
Elevated environmental temperature and methamphetamine neurotoxicity.
|
Environ Res
|
2003
|
0.98
|
20
|
Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure.
|
Neurotoxicology
|
2009
|
0.94
|
21
|
AMP-activated protein kinase phosphorylation in brain is dependent on method of killing and tissue preparation.
|
J Neurochem
|
2007
|
0.93
|
22
|
Low-level human equivalent gestational lead exposure produces supernormal scotopic electroretinograms, increased retinal neurogenesis, and decreased retinal dopamine utilization in rats.
|
Environ Health Perspect
|
2008
|
0.93
|
23
|
Systems analysis of genetic variation in MPTP neurotoxicity in mice.
|
Neurotoxicology
|
2013
|
0.92
|
24
|
Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation.
|
J Neurochem
|
2006
|
0.92
|
25
|
Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?
|
Metabolism
|
2008
|
0.92
|
26
|
NeuroAIDS, drug abuse, and inflammation: building collaborative research activities.
|
J Neuroimmune Pharmacol
|
2006
|
0.91
|
27
|
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum.
|
J Neurochem
|
2011
|
0.90
|
28
|
Depression, cytokines, and glial function.
|
Metabolism
|
2005
|
0.88
|
29
|
Associations of cortical astrogliosis with cognitive performance and dementia status.
|
J Alzheimers Dis
|
2004
|
0.87
|
30
|
An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.
|
CNS Drugs
|
2008
|
0.86
|
31
|
Calcium/calmodulin-dependent protein kinase II activity and expression are altered in the hippocampus of Pb2+-exposed rats.
|
Brain Res
|
2005
|
0.86
|
32
|
Autoantibodies to neurotypic and gliotypic proteins as biomarkers of neurotoxicity: assessment of trimethyltin (TMT).
|
Neurotoxicology
|
2007
|
0.86
|
33
|
Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse.
|
Brain Res
|
2002
|
0.85
|
34
|
Personalized medicine in major depressive disorder -- opportunities and pitfalls.
|
Metabolism
|
2012
|
0.85
|
35
|
Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process.
|
Neurotoxicology
|
2004
|
0.83
|
36
|
The pharmacology of wakefulness.
|
Metabolism
|
2006
|
0.83
|
37
|
Gestational lead exposure selectively decreases retinal dopamine amacrine cells and dopamine content in adult mice.
|
Toxicol Appl Pharmacol
|
2011
|
0.81
|
38
|
Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.
|
Mov Disord
|
2012
|
0.81
|
39
|
Brain concentrations of d-MDMA are increased after stress.
|
Psychopharmacology (Berl)
|
2004
|
0.81
|
40
|
Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation, and behavior in the forced-swim test.
|
J Pharmacol Exp Ther
|
2011
|
0.81
|
41
|
Development of an animal model to study the potential neurotoxic effects associated with welding fume inhalation.
|
Neurotoxicology
|
2006
|
0.80
|
42
|
d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.
|
Brain Res
|
2002
|
0.80
|
43
|
Neurotoxic esterase: not so toxic?
|
Nat Genet
|
2003
|
0.79
|
44
|
Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain.
|
Brain Res
|
2010
|
0.79
|
45
|
Corticosterone regulates expression of CCL2 in the intact and chemically injured hippocampus.
|
Neurosci Lett
|
2006
|
0.78
|
46
|
Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis.
|
Neurotoxicol Teratol
|
2009
|
0.78
|
47
|
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.
|
Psychopharmacology (Berl)
|
2014
|
0.77
|
48
|
Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines.
|
Bioorg Med Chem
|
2011
|
0.77
|
49
|
Regulatory developmental neurotoxicity testing: a model study focussing on conventional neuropathology endpoints and other perspectives.
|
Environ Toxicol Pharmacol
|
2005
|
0.76
|
50
|
Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
|
J Pharmacol Exp Ther
|
2003
|
0.76
|
51
|
Protracted exposure to supraphysiological levels of corticosterone does not cause neuronal loss or damage and protects against kainic acid-induced neurotoxicity in the hippocampus of C57BL/6J mice.
|
Neurotoxicology
|
2009
|
0.76
|
52
|
Microscale sample deposition onto hydrophobic target plates for trace level detection of neuropeptides in brain tissue by MALDI-MS.
|
J Mass Spectrom
|
2005
|
0.76
|
53
|
Discovery of novel alpha7 nicotinic receptor antagonists.
|
Bioorg Med Chem Lett
|
2010
|
0.76
|